An isotretinoin dose needs three descriptions: how much you take each day, which formulation you take and how your total exposure develops over the course. Capsule strength alone answers none of those questions completely. A dermatologist chooses and adjusts the prescription using acne severity, weight, response, adverse effects and relevant test results.
Published dose ranges explain how clinicians think. They do not provide a personal prescription or permission to increase treatment because a breakout appears.
Daily dose and capsule strength
Daily dose means the total amount taken across the day. Capsule strength means the amount in one capsule. A prescription can use more than one capsule strength to reach the intended total, which makes the written schedule more reliable than a memory of the color or size of your capsules.
Conventional isotretinoin labeling commonly describes 0.5-1 mg/kg/day in two divided doses with food. The mg/kg figure relates the daily amount to body weight. Some adults with very severe disease may require a different amount under specialist supervision; that possibility does not make the upper end a starting target for everyone. 1
The clinician may round a calculated amount to available strengths or use a schedule that reflects tolerability. Do not change a written prescription to make it match a number you calculated from a general range.
Formulation changes the comparison
Absorica labeling describes 0.5-1 mg/kg/day, while Absorica LD labeling describes 0.4-0.8 mg/kg/day. Both cited labels use two divided doses and allow administration without regard to meals. The manufacturer states that the products are not substitutable because their bioavailability differs. 2
| Term | What it measures | What it does not establish |
|---|---|---|
| mg per capsule | Amount inside one capsule | The total prescribed amount per day |
| mg/kg/day | Daily amount relative to body weight | Whether that amount suits your formulation or health |
| Total milligrams | Sum of the amount taken over time | Exposure relative to body size |
| Cumulative mg/kg | Total milligrams divided by body weight | A guarantee of permanent clearance |
If the pharmacy changes the formulation, the prescriber should confirm the replacement schedule. Matching the milligrams printed on two boxes cannot resolve every substitution question.
Why the starting amount may differ
Two patients with the same weight may receive different starting plans. One may have severe inflammation and a history of an early flare; the other may already have troublesome dryness or a medical factor that affects monitoring. Tolerability can determine whether a patient can continue treatment long enough to obtain benefit.
The discussion should also cover your routine. A prescription that requires food needs a plan you can follow reliably. A night shift, restricted eating pattern or recurrent nausea may deserve attention before a dose increase appears to be the answer to a weak response.
Tell the clinician about missed doses without trying to compensate first. A course record helps distinguish inadequate exposure from a medicine that has not controlled the disease despite appropriate use.
Lower-dose treatment
Clinicians sometimes choose a daily amount below the conventional range when adverse effects or other risks make that approach reasonable. NICE advises considering a dose below 0.5 mg/kg/day for people at increased risk of adverse effects or those who develop them. 3
A lower dose may reduce some dose-related symptoms, but it does not remove pregnancy risk, interactions or the need for follow-up. It can also require a longer course. Describe which effects interfere with treatment so the clinician can weigh continuing, reducing, pausing or changing the plan.
Intermittent and very-low-dose regimens appear in research and practice, but they are not interchangeable with a standard prescription. The evidence, indication and expected course differ. Do not design a schedule from another patient's account of taking capsules a few times each week.
What cumulative dose means
Cumulative dose describes exposure across the whole course. A conventional calculation adds the milligrams actually taken, then divides that total by body weight in kilograms. Pauses and dose changes affect the total; a calendar month does not always represent the same exposure.
NICE commonly uses a cumulative range of 120-150 mg/kg, while allowing an earlier endpoint after adequate response and no new lesions for 4-8 weeks. That guidance makes response and tolerability part of the decision rather than turning the calculation into a target to pursue regardless of symptoms. 3
US product labeling also describes treatment duration and clinical response. Different clinical settings may use different stopping approaches. Ask which endpoint your prescriber uses and what would change it.
Does more exposure prevent relapse?
Long-term control depends on more than the largest amount taken on a single day. A clinician considers the course as a whole, including treatment response, sustained clearance and tolerability. The article on acne recurrence explains what relapse studies measure and how those findings differ from an individual prescription.
The clinician must also account for disease pattern, adverse effects and whether apparent recurrence truly needs systemic treatment. A cumulative number cannot substitute for that assessment.
When a dose review makes sense
Contact the clinic when symptoms interfere with sleep, activity, eating or daily skin care, or when new symptoms concern you. Scheduled reviews also give the prescriber an opportunity to assess new lesions and laboratory results before deciding whether to increase exposure.
- Persistent dryness that cracks or bleeds may need more than another lip product.
- Muscle or joint symptoms may require review of exercise and other causes.
- New headaches, visual symptoms or major mood changes need prompt assessment rather than routine dose experimentation.
- Abnormal triglycerides or liver enzymes can alter the treatment plan even when your skin feels well.
- A product change should trigger confirmation of the administration instructions.
Do not treat every symptom with a supplement while keeping the dose unchanged. Vitamin A-containing products can add toxicity, and some other supplements complicate the interpretation of symptoms or tests.
Missed doses and interruptions
The cited US labels advise skipping a missed dose instead of taking two together. An interrupted course may need a revised schedule, renewed authorization or another clinical review. It does not justify swallowing extra capsules to catch up before an appointment. 1, 2
Record the approximate dates of interruptions and which amount you actually took. That information improves the cumulative exposure estimate and avoids confusion when the prescriber compares progress with the original plan.
Can I stay on a small dose indefinitely?
Long-term low-dose use requires a separate specialist discussion. Standard course instructions do not establish that indefinite use is appropriate, and a small amount does not remove ongoing risks or pregnancy precautions.
Should the dose rise every month?
No fixed monthly increase suits everyone. The dermatologist reviews response and tolerability. Staying at the same amount, reducing it or pausing can each make sense under different circumstances.
What if I reach the planned total but still get new nodules?
Arrange a review of the remaining disease, administration, formulation and treatment history. The clinician can decide whether to extend treatment, investigate another contributor or plan another approach. Do not continue with leftover capsules until the skin matches a promised result.
Sources
- DailyMed. Isotretinoin capsules prescribing information, revised August 2026. View source
- FDA. Absorica and Absorica LD prescribing information, revised June 2026. View source
- NICE. Acne vulgaris: management, NG198. Recommendations, updated 2026. View source
- Lai J, et al. Acne relapse and isotretinoin retrial in patients with acne. JAMA Dermatology, 2025. View source